SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $25M invested in Salarius Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

99% less call options, than puts

Call options by funds: $1K | Put options by funds: $83K

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
$83K
Net Calls
Net Calls Change

Top Buyers

1
+$322K
2
+$301K
3
+$188K

Top Sellers

1
-$4.34M
2
-$250K
3
-$195K
4
SIM
Spark Investment Management
New York
-$93K
5
Northern Trust
Northern Trust
Illinois
-$80K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$20K
27
$3K
28
$2K
29
$1K
30
$1K
31
$1K
32
$1K
33
$35
34
–
35
–
36
–
1
2